Journal
INFLUENZA AND OTHER RESPIRATORY VIRUSES
Volume 2, Issue 6, Pages 229-235Publisher
WILEY
DOI: 10.1111/j.1750-2659.2008.00060.x
Keywords
Influenza vaccine; influenza; human; adjuvants; immunologic; intradermal injections
Categories
Ask authors/readers for more resources
Challenges facing seasonal and pandemic influenza vaccination include: increasing the immunogenicity of seasonal vaccines for the most vulnerable, increasing vaccination coverage against seasonal influenza, and developing vaccines against pandemic strains that are immunogenic with very low quantities of antigen to maximize the number of people who can be vaccinated with a finite production capacity. We review Sanofi Pasteur's epidemic and pandemic influenza research and development programmes with emphasis on two key projects: intradermal influenza vaccine for seasonal vaccination of both elderly and younger adults, and pandemic influenza vaccine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available